151 related articles for article (PubMed ID: 29103775)
1. Cyclin D1 promoter -56 and -54bp CpG un-methylation predicts invasive progression in arsenic-induced Bowen's disease.
Liao WT; You HL; Chai CY; Lee CH; Lan CE; Chang SJ; Yu CL; Yu HS
J Dermatol Sci; 2018 Feb; 89(2):191-197. PubMed ID: 29103775
[TBL] [Abstract][Full Text] [Related]
2. Aneuploidy in Bowen's disease.
Newton JA; Camplejohn RS; McGibbon DH
Br J Dermatol; 1986 Jun; 114(6):691-4. PubMed ID: 3718863
[TBL] [Abstract][Full Text] [Related]
3. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
[TBL] [Abstract][Full Text] [Related]
4. High frequency of DNA aneuploidy detected by DNA flow cytometry in Bowen's disease.
Kawara S; Takata M; Takehara K
J Dermatol Sci; 1999 Sep; 21(1):23-6. PubMed ID: 10468188
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen's disease.
Liao WT; Yu CL; Lan CC; Lee CH; Chang CH; Chang LW; You HL; Yu HS
Carcinogenesis; 2009 Jun; 30(6):1064-72. PubMed ID: 19376847
[TBL] [Abstract][Full Text] [Related]
6. Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers.
Lee CH; Wu SB; Hong CH; Chen GS; Wei YH; Yu HS
J Invest Dermatol; 2013 Jul; 133(7):1890-900. PubMed ID: 23370535
[TBL] [Abstract][Full Text] [Related]
7. Aneuploidy in actinic keratosis and Bowen's disease--increased risk for invasive squamous cell carcinoma?
Biesterfeld S; Pennings K; Grussendorf-Conen EI; Böcking A
Br J Dermatol; 1995 Oct; 133(4):557-60. PubMed ID: 7577583
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan.
Hsu YH; Li SY; Chiou HY; Yeh PM; Liou JC; Hsueh YM; Chang SH; Chen CJ
Mutat Res; 1997 Jun; 386(3):241-51. PubMed ID: 9219562
[TBL] [Abstract][Full Text] [Related]
9. Arsenic carcinogenesis in the skin.
Yu HS; Liao WT; Chai CY
J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
[TBL] [Abstract][Full Text] [Related]
10. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
[TBL] [Abstract][Full Text] [Related]
11. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
12. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers.
Lee CH; Wu SB; Hong CH; Liao WT; Wu CY; Chen GS; Wei YH; Yu HS
Am J Pathol; 2011 May; 178(5):2066-76. PubMed ID: 21514422
[TBL] [Abstract][Full Text] [Related]
13. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease.
Yeh S; How SW; Lin CS
Cancer; 1968 Feb; 21(2):312-39. PubMed ID: 4952508
[No Abstract] [Full Text] [Related]
14. Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis.
Lee CH; Yu HS
Front Biosci (Schol Ed); 2016 Jun; 8(2):312-20. PubMed ID: 27100709
[TBL] [Abstract][Full Text] [Related]
15. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
16. The subsequent risk of internal cancer with Bowen's disease. A population-based study.
Chute CG; Chuang TY; Bergstralh EJ; Su WP
JAMA; 1991 Aug; 266(6):816-9. PubMed ID: 1865520
[TBL] [Abstract][Full Text] [Related]
17. Bowen's disease of the plantar arch.
Allen RB; Richardson DR; Futrell JW
Cutis; 1979 Jun; 23(6):805-7. PubMed ID: 467101
[TBL] [Abstract][Full Text] [Related]
18. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease.
Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y
J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614
[TBL] [Abstract][Full Text] [Related]
19. Multiple Bowen's diseases and basal cell carcinomas in a patient with acute promyelocytic leukemia treated with arsenic trioxide: A case report and effective treatment with photodynamic therapy.
Ding C; Ma YY; Wang P; Liu J
Dermatol Ther; 2018 Nov; 31(6):e12718. PubMed ID: 30239071
[TBL] [Abstract][Full Text] [Related]
20. Immunological dysfunction in chronic arsenic exposure: From subclinical condition to skin cancer.
Yu S; Liao WT; Lee CH; Chai CY; Yu CL; Yu HS
J Dermatol; 2018 Nov; 45(11):1271-1277. PubMed ID: 30144155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
